TY - JOUR
T1 - Biosynthetic Origin of the Oxygen Atoms of Aquayamycin
T2 - Aspects for the Biosynthesis of the Urdamycin Family and for Aquayamycin-Containing Angucycline Antibiotics in General
AU - Udvarnoki, Györgyi
AU - Henkel, Thomas
AU - Machinek, Reinhard
AU - Rohr, Jürgen
PY - 1992/2/1
Y1 - 1992/2/1
N2 - Experiments with 18O2 and [l-13C,18O2]acetate determined the biosynthetic origin of the oxygen atoms of aquayamycin (1), which is the aglycon moiety of the urdamycins A (2, kerriamycin B) and G (3, OM 4842) and the most frequently occurring aglycon among the angucyclines. The fact that 4a-0 derives from acetate and 12b-0 from molecular oxygen leads to the postulation of a biosynthetic scheme, in which a hypothetical tetracyclic compound 9 similar to SF-2315 A (10) and urdamycinone F (7) are key intermediates. Oxygen deficiency experiments with the urdamycin producer Streptomyces fradiae (strain Tü 2717) resulted in the production of only urdamycin B (4), when the oxygen level was reduced gradiently from 20% to 5% during the fermentation process. This result is in conformance with the postulated biosynthesis scheme; i.e., suppression of the 12bmonooxygenase leads to a shunt pathway with 4 being the final product.
AB - Experiments with 18O2 and [l-13C,18O2]acetate determined the biosynthetic origin of the oxygen atoms of aquayamycin (1), which is the aglycon moiety of the urdamycins A (2, kerriamycin B) and G (3, OM 4842) and the most frequently occurring aglycon among the angucyclines. The fact that 4a-0 derives from acetate and 12b-0 from molecular oxygen leads to the postulation of a biosynthetic scheme, in which a hypothetical tetracyclic compound 9 similar to SF-2315 A (10) and urdamycinone F (7) are key intermediates. Oxygen deficiency experiments with the urdamycin producer Streptomyces fradiae (strain Tü 2717) resulted in the production of only urdamycin B (4), when the oxygen level was reduced gradiently from 20% to 5% during the fermentation process. This result is in conformance with the postulated biosynthesis scheme; i.e., suppression of the 12bmonooxygenase leads to a shunt pathway with 4 being the final product.
UR - http://www.scopus.com/inward/record.url?scp=0026562230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026562230&partnerID=8YFLogxK
U2 - 10.1021/jo00030a041
DO - 10.1021/jo00030a041
M3 - Article
AN - SCOPUS:0026562230
SN - 0022-3263
VL - 57
SP - 1274
EP - 1276
JO - Journal of Organic Chemistry
JF - Journal of Organic Chemistry
IS - 4
ER -